D‐dimer levels and risk of recurrence following provoked venous thromboembolism: Findings from the RIETE registry

O Avnery, M Martin, A Bura‐Riviere… - Journal of internal …, 2020 - Wiley Online Library
Background Patients with venous thromboembolism (VTE) secondary to transient risk factors
may develop VTE recurrences after discontinuing anticoagulation. Identifying at‐risk patients …

Extended anticoagulation after venous thromboembolism: should it be done?

CJ Fernandes, D Calderaro, B Piloto… - Therapeutic …, 2019 - journals.sagepub.com
Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited
disease. However, pathophysiological and epidemiological data suggest that in most …

[HTML][HTML] Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

M Marcucci, A Iorio, JD Douketis, S Eichinger… - Journal of Thrombosis …, 2015 - Elsevier
Background In order to stratify patients with a first unprovoked venous thromboembolism
(VTE) according to their recurrence risk and to identify those who would actually benefit from …

Unprovoked venous thromboembolism: short term or indefinite anticoagulation? Balancing long-term risk and benefit

M Rodger, M Carrier, E Gandara, G Le Gal - Blood reviews, 2010 - Elsevier
Whether to continue oral anticoagulant therapy indefinitely after completing 3 to 6months of
oral anticoagulant therapy for “unprovoked” venous thromboembolism (VTE), is one of the …

Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry

W Ageno, G Agnelli, D Imberti, M Moia, G Palareti… - Thrombosis research, 2008 - Elsevier
INTRODUCTION: Signs and symptoms of venous thromboembolism (VTE) are non-specific
and thus can make diagnosis difficult, even for an experienced clinician. We aimed to …

Risk assessment model for venothromboembolism in post-hospitalized patients

SH Yale, SC Medlin, H Liang, T Peters - International …, 2005 - search.proquest.com
AIM: Venothromboembolism (VTE) is an important condition in hospitalized patients
accounting for significant morbidity and mortality, and the risk of VTE often continues post …

Duration of anticoagulation following venous thromboembolism: a meta-analysis

D Ost, J Tepper, H Mihara, O Lander, R Heinzer, A Fein - Jama, 2005 - jamanetwork.com
ContextPatients with venous thromboembolism (VTE) are susceptible to recurrent events,
but whether prolonging anticoagulation is warranted in patients with VTE remains …

The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH

W Ageno, A Squizzato, PS Wells, HR Büller… - Journal of Thrombosis …, 2013 - jthjournal.org
This document is intended to give clinical guidance for the diagnosis of symptomatic
recurrent pulmonary embolism (PE) and/or deep vein thrombosis (DVT). We define recurrent …

[HTML][HTML] Sex, age and normal post‐anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension

B Cosmi, C Legnani, A Tosetto, V Pengo… - Journal of Thrombosis …, 2010 - Elsevier
Background: The PROLONG randomized study showed that patients with an abnormal D‐
dimer after anticoagulation suspension for a first unprovoked episode of venous …

[HTML][HTML] Provoked versus unprovoked venous thromboembolism: findings from GARFIELD‐VTE

W Ageno, A Farjat, S Haas, JI Weitz… - Research and practice …, 2021 - Elsevier
Introduction Venous thromboembolism (VTE) has a long‐term risk of recurrence, dependent
on the presence or absence of provoking risk factors at the time of the event. Objective To …